Effects of visual sexual stimuli and apomorphine SL on cerebral activity in men with erectile dysfunction

被引:38
|
作者
Hagemann, JH
Berding, G
Bergh, S
Sleep, DJ
Knapp, WH
Jonas, U
Stief, CG
机构
[1] Univ Sch Med, Dept Urol & Pediat Urol, D-30625 Hannover, Germany
[2] Univ Sch Med, Dept Nucl Med, Hannover, Germany
[3] Abbott Labs, Abbott Pk, IL 60064 USA
关键词
erectile dysfunction; sexual arousal; apomorphine; functional imaging;
D O I
10.1016/S0302-2838(03)00002-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The present study investigates whether cerebral activation during visually evoked sexual arousal is different in patients with erectile dysfunction (ED) compared to the known pattern observed in healthy men, and additionally how cerebral activity during visual sexual stimulation is modified by treatment with apomorphine SL and whether the observed cerebral activity correlates with penile rigidity. Patients and Methods: Cerebral activity was measured before and after treatment in 12 patients with erectile dysfunction randomised to receive either apomorphine SL or placebo using [O-15]H2O-PET. Two PET scans were performed prior to administration of the study medication, the first after a neutral audiovisual stimulus and the second following a sexually stimulating audiovisual presentation. After receiving the study medication, patients were subjected to two additional scans each preceded by a sexually stimulating stimulus. Penile rigidity was assessed with the RigiScan(R) device. Evaluation for significant regional cerebral activation was performed using statistical parametric mapping (SPM99). Results: Cerebral activity increased significantly after the sexually stimulating video sequence compared to the neutral one in the inferior frontal cortex (Brodmann areas [BA] 47, 10, 11) and the rostral anterior cingulate (BA 32), and cerebral activity was observed to decrease in both inferior temporal cortices (BA 20). 4 out of 6 patients showed significant penile rigidity after apomorphine SL and in none of those receiving placebo. Apomorphine SL was observed to increase cerebral activity in the right superior prefrontal area (BA 6) that was not Seen with placebo, while neither apomorphine SL nor placebo produced decreased cerebral activity. Penile rigidity correlated with increased cerebral activity in the anterior cingulum and right prefrontal cortex, and with decreased activity in the temporal cortex. Conclusions: In patients with erectile dysfunction, the pattern of increased and decreased cerebral activity in response to visual sexual stimuli in this study is similar to that reported in the literature in healthy men. Apomorphine SL appears to induce additional cerebral activity in the right prefrontal cortex, an area previously shown to be associated with sexual arousal in male volunteers during orgasm. This increased cerebral activity was associated with penile rigidity, further supporting the conclusion that apomorphine SL improves erectile function in men with ED by enhancing the natural central erectile signals that normally occur during sexual stimulation. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:412 / 420
页数:9
相关论文
共 50 条
  • [1] Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men
    P Gontero
    R D'Antonio
    G Pretti
    F Fontana
    M Panella
    E Kocjancic
    G Allochis
    B Frea
    [J]. International Journal of Impotence Research, 2005, 17 : 80 - 85
  • [2] Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men
    Gontero, P
    D'Antonio, R
    Pretti, G
    Fontana, F
    Panella, M
    Kocjancic, E
    Allochis, G
    Frea, B
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2005, 17 (01) : 80 - 85
  • [3] Efficacy of apomorphine SL in erectile dysfunction
    Mirone, VG
    Stief, CG
    [J]. BJU INTERNATIONAL, 2001, 88 : 25 - 29
  • [4] Sequential administration enhances the effect of apomorphine SL in men with erectile dysfunction
    Heaton, JPW
    Dean, J
    Sleep, DJ
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2002, 14 (01) : 61 - 64
  • [5] The role of apomorphine SL in the treatment of erectile dysfunction
    Montorsi, F
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (03) : 4 - 11
  • [6] Oral treatment of erectile dysfunction with apomorphine SL
    Altwein, JE
    Keuler, FU
    [J]. UROLOGIA INTERNATIONALIS, 2001, 67 (04) : 257 - 263
  • [7] Local and distributed effects of apomorphine sublingual on cortical activity in men with erectile dysfunction
    Hagemann, JH
    Berding, G
    Bergh, S
    Knapp, WH
    Jonas, U
    Stief, C
    Sleep, DJ
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 246 - 246
  • [8] Rapid communication sequential administration enhances the effect of apomorphine sl in men with erectile dysfunction
    Heaton J.P.W.
    Dean J.
    Sleep D.J.
    [J]. International Journal of Impotence Research, 2002, 14 (1) : 61 - 64
  • [9] Safety and tolerability of apomorphine SL in patients with erectile dysfunction
    Buvat, J
    Montorsi, F
    [J]. BJU INTERNATIONAL, 2001, 88 : 30 - 35
  • [10] The role of apomorphine SL in the treatment of male erectile dysfunction
    Heaton, JPW
    Altwein, JE
    [J]. BJU INTERNATIONAL, 2001, 88 : 36 - 38